Fractus, S.A. v. AT&T Mobility LLC, No. 2:18-cv-00135 (E.D. Tex. Feb. 6, 2019)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is Intervenor-Defendant CellMax Technologies AB’s (“CellMax”) Unopposed Motion for Leave to Supplement Defendants’ Invalidity Contentions (the “Motion). (Dkt. No. 120.) On January 17, 2019, the Co urt held a hearing on the above -pending motion. At that hearing, the Parties represented to the Court on the record that this proposed additional prior art reference will not be used to present a new invalidity theory that differs from that of the named Defendant cellular carriers.